Denintuzumab (hBU 12) is a recombinant humanized monoclonal antibody targeting CD19. This antibody serves as a critical component in the development of antibody-drug conjugates (ADCs), specifically in the synthesis of Denintuzumab Mafodotin (SGN-CD19A). Denintuzumab Mafodotin is primarily utilized in research focused on acute lymphoblastic leukemia, providing a targeted therapeutic approach by delivering cytotoxic drugs directly to CD19-expressing cells. This specificity makes Denintuzumab an invaluable tool in the advancement of leukemia therapeutics.
Denintuzumab (hBU 12) is a recombinant humanized monoclonal antibody targeting CD19. This antibody serves as a critical component in the development of antibody-drug conjugates (ADCs), specifically in the synthesis of Denintuzumab Mafodotin (SGN-CD19A). Denintuzumab Mafodotin is primarily utilized in research focused on acute lymphoblastic leukemia, providing a targeted therapeutic approach by delivering cytotoxic drugs directly to CD19-expressing cells. This specificity makes Denintuzumab an invaluable tool in the advancement of leukemia therapeutics.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
